发明名称 |
Mutant G-CSF fusion protein, and preparation and use thereof |
摘要 |
The present invention relates to a mutant G-CSF fusion protein. The mutant G-CSF fusion protein is a fusion protein having the activity of stimulating the proliferation of neutrophilic granulocytes, and having a basic structure of G-CSF/carrier protein or carrier protein/G-CSF; wherein the G-CSF moiety comprises multipoint substitutions thus resulting in changes in biological activity and binding affinity. Compared with existing products, the mutant G-CSF fusion protein in the present invention has longer half-life and higher biological activity. Administration of the pharmaceutical preparation containing this mutant G-CSF fusion protein could be used in the treating neutropenia. |
申请公布号 |
US8785597(B2) |
申请公布日期 |
2014.07.22 |
申请号 |
US201013575752 |
申请日期 |
2010.06.30 |
申请人 |
Jiangsu T-Mab Biopharma Co., Ltd. |
发明人 |
Wen Xiaofang;Wu Yiliang;Wang Yefei;Yang Zhiyu;Fan Min;Wang Yujiao;Fang Xiaochun;Lu You |
分类号 |
C07K1/00;C12P21/04;C12N15/00;C12N5/00;A61K38/18 |
主分类号 |
C07K1/00 |
代理机构 |
Sinorica, LLC |
代理人 |
Chow Ming;Sinorica, LLC |
主权项 |
1. A mutant G-CSF fusion protein, comprising a G-CSF moiety and a carrier protein; said G-CSF moiety being derived from a human G-CSF protein with its amino acid sequence set forth in SEP ID NO: 1; said G-CSF moiety comprising at least one of the mutations of K34H, L35I, K40H and L41I; and said mutant G-CSF fusion protein stimulating proliferations of neutrophilic granulocytes. |
地址 |
Jiangsu Province CN |